This activity is part of PER's Integrated Oncology Learning Series:
A Focus on Thoracic Malignancies
Sixth Annual Symposium on the Future of Lung Cancer
Release Date: December 13, 2009| Dec 5, 2009, Washington, DC
Impact of Histology on Response and Patient Selection
Nathan A. Pennell
Debate: Early Second-line Therapy/Maintenance Therapy Is Standard of Care - Pro
H. Jack West
Debate: Early Second-line Therapy/Maintenance Therapy Is Standard of Care - Con
Nasser H. Hanna
Optimizing EGFR Inhibition in Lung Cancer
Lecia V. Sequist
New Indications for Antiangiogenic Agents
David R. Spigel
Multidisciplinary Management of Locoregional NSCLC
Todd Demmy
David S. Ettinger
Quynh-Thu Le
Management of Metastatic NSCLC: Markers, Selection of Therapy, Maintenance Therapy, Supportive Care
Todd Demmy
David S. Ettinger
Quynh-Thu Le
New Systemic Therapies in Locally Advanced NSCLC
Ramaswamy Govindan
Surgery in Locally Advanced NSCLC
Frank C. Detterbeck
Inhibiting EML4-ALK in Lung Cancer
Alice Tsang Shaw
Novel Disruptors of Tumor Vasculature
David R. Spigel
Inhibiting Histone Deacetylases
Suresh Ramalingam
mTOR Inhibitors
Bruce E. Johnson
IGF-1R Inhibitors
Corey Langer
HSP90 Inhibitors
Scott N. Gettinger
To view the streaming Flash Video lectures, click the "Listen to the Presentation" link. The latest version of Flash Player is recommended to view the Flash video.
Click here to download Flash Player >>
To download Podcast-ready movies, click "Download the Presentation," and select "Save target as..." The latest version of Quicktime is recommended to view these movies.
Click here to download Quicktime >>